APA

Mellor A. L., Baban B., Chandler P. R., Manlapat A., Kahler D. J. & Munn D. H. (20051129). Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. : Journal of immunology (Baltimore, Md. : 1950).

Chicago

Mellor Andrew L, Baban Babak, Chandler Phillip R, Manlapat Anna, Kahler David J and Munn David H. 20051129. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. : Journal of immunology (Baltimore, Md. : 1950).

Harvard

Mellor A. L., Baban B., Chandler P. R., Manlapat A., Kahler D. J. and Munn D. H. (20051129). Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. : Journal of immunology (Baltimore, Md. : 1950).

MLA

Mellor Andrew L, Baban Babak, Chandler Phillip R, Manlapat Anna, Kahler David J and Munn David H. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. : Journal of immunology (Baltimore, Md. : 1950). 20051129.